Dalde, Khasimira A.
HRN: 16-62-16 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2024
CEFUROXIME 750MG (VIAL)
10/17/2024
10/24/2024
IV
500 Mg
Q 8 Hours
PCAP-C
Waiting Final Action